Enzalutamide with or without Abiraterone Acetate and Prednisone in Treating Patients with Castration-Resistant Metastatic Prostate Cancer

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeAgeTrial IDs
Phase IIIBiomarker/Laboratory analysis, Treatment18 and overA031201
NCI-2013-01737, CALGB-A031201, NCT01949337

Trial Description

Summary

This randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone acetate, and prednisone in treating patients with prostate cancer that has spread to other places in the body and keeps growing even when the amount of testosterone in the body is reduced to very low levels. Androgens can cause the growth of prostate cancer cells. Drugs, such as enzalutamide, abiraterone acetate, and prednisone, may lessen the amount of androgens made by the body.

Further Study Information

PRIMARY OBJECTIVES:

I. To compare the overall survival of patients with progressive metastatic castration-resistant prostate cancer (CRPC) treated with either a) enzalutamide only or b) enzalutamide with abiraterone (abiraterone acetate) and prednisone.

SECONDARY OBJECTIVES:

I. To assess the grade 3 or higher toxicity profile and compare safety by treatment arm.

II. To assess and compare post-treatment prostate-specific antigen (PSA) declines by treatment arm.

III. To compare radiographic progression free survival defined by Prostate Cancer Working Group 2 (PCWG2), and objective response rate, by treatment arm.

IV. To test for radiographic progression free survival (rPFS) treatment interaction in predicting overall survival.

V. To assess pre- and post-treatment measures of tumor burden and bone activity using sodium fluoride (NaF) positron emission tomography (PET)/computed tomography (CT) and technetium (Tc) methylene diphosphonate (MDP) bone scintigraphy and correlate these measures with overall survival.

VI. To develop and validate prognostic and predictive models of overall survival that include baseline clinical and molecular markers.

TERTIARY OBJECTIVES:

I. To determine whether pre-treatment serum adrenal androgen (SA) levels are prognostic factors of overall survival and to test whether SA levels are predictive factors of overall survival.

II. To evaluate specific pre-treatment ribonucleic acid (RNA) levels as prognostic factors for overall survival (OS), including the 6- and 9-gene signatures, the circulating tumor cells (CTC) RNA profile, and the circulating tumor stem cell RNA profile.

III. To evaluate the predictive ability of specific pre-treatment and post-treatment RNA, levels on the OS and progression free survival (PFS).

IV. To evaluate specific pre-treatment microRNA levels as prognostic factors for OS.

V. To test whether the microRNA are predictive factors for overall survival.

VI. To determine whether pre-treatment angiokine levels are prognostic factors for OS and PFS.

VII. To test whether pretreatment angiokine levels are predictive factors for OS and PFS and to assess whether post-treatment angiokine levels are predictive factors for OS and PFS.

VIII. To investigate a drug by cytochrome P450, family 17, subfamily A, polypeptide 1 (CYP17A1) interaction with respect to overall survival.

IX. To assay candidate variants and loci hypothesized to be associated with other clinical phenotypes (e.g., progression-free survival or toxicity) or other expression quantitative trait loci (eQTLs).

X. To identify specific single-nucleotide polymorphisms (SNPs) and/or copy number variations that are associated with the response to and toxicity associated with therapy.

XI. To define the effect of abiraterone on reducing enzalutamide metabolic clearance (i.e. increasing enzalutamide area under the curve [AUC]) when the drugs are used in combination.

XII. To define the exposure (AUC) toxicity and exposure (AUC) anti-tumor effect relationship, including biomarkers for enzalutamide alone and enzalutamide combined with abiraterone in prostate cancer patients.

XIII. To develop a population pharmacokinetic model for enzalutamide alone and enzalutamide combined with abiraterone taking account of relevant intrinsic and extrinsic factors.

XIV. To determine the intrapatient and interpatient variability of abiraterone exposure (AUC) in prostate cancer patients receiving abiraterone when combined with enzalutamide.

XV. To determine the intra-patient and inter-patient variability of enzalutamide exposure (AUC) in prostate cancer patients receiving enzalutamide alone and abiraterone plus enzalutamide.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM A: Patients receive enzalutamide orally (PO) once daily (QD) on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.

ARM B: Patients receive enzalutamide PO QD, abiraterone acetate PO QD, and prednisone PO twice daily (BID) on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 12 weeks for 5 years and then every 6 months for 5 years.

Eligibility Criteria

Inclusion Criteria:

Testosterone =< 50 ng/dL (1.7 nmol/L)

Albumin >= 3 g/dl

Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) =< 2 x ULN

Bilirubin =< 1.5 x ULN

Creatinine =< 2 x upper limits of normal (ULN)

Asymptomatic or mildly symptomatic from prostate cancer

A score of 0-1 on Brief Pain Inventory-Short Form (BPI-SF) Question #3 (worst pain in last 24 hours) will be considered asymptomatic, and a score of 2-3 will be considered mildly symptomatic

No clinically significant cardiovascular disease including:

Myocardial infarction (MI) within 6 months

Uncontrolled angina within 3 months

Congestive heart failure (CHF) with New York Heart Association (NYHA) class 3 or 4 in the past, unless a screening echocardiogram (echo) or multi gated acquisition scan (MUGA) performed within three months demonstrates an ejection fraction (EF) > 45%

History of clinically significant ventricular arrhythmias (e.g., ventricular tachycardia, ventricular fibrillation, torsades de pointes)

History of Mobitz II second degree or third degree heart block without a permanent pacemaker in place

Hypotension (systolic blood pressure [BP] < 86 mmHg) or bradycardia (< 50 beats per minute [bpm]) at screening

Uncontrolled hypertension (systolic BP > 170 mmHg or diastolic BP > 105 mmHg at screening)

No structurally unstable bone lesions suggesting impending fracture

No planned palliative procedures for alleviation of bone pain such as radiation therapy or surgery

No known or suspected brain metastases (NOTE: patients with treated epidural disease are allowed)

Patients must maintain ongoing androgen deprivation therapy with a GnRH analogue, antagonist, or bilateral orchiectomy (i.e., surgical or medical castration)

Patients receiving bisphosphonate therapy or denosumab must have been on a stable dose for at least 4 weeks prior to enrollment

No prior radiation therapy or beta-emitting radionuclide therapy for the treatment of metastasis within four weeks prior to enrollment

No use of systemic steroids greater than the equivalent of 10 mg of prednisone/prednisolone per day within 4 weeks prior to enrollment

No use of herbal products that may decrease PSA levels within 4 weeks prior to enrollment

No treatment with any of the following for prostate cancer within 4 weeks prior to enrollment:

Hormonal therapy (e.g., androgen receptor [AR] antagonists, 5 alpha reductase inhibitors, estrogens); Note: treatment with bicalutamide and nilutamide within 6 weeks prior to enrollment is not allowed; treatment with flutamide within 4 weeks prior to enrollment is not allowed; treatment with all other gonadotropin-releasing hormone (GnRH) analogues or antagonists is allowed

Chemotherapy

Biologic therapy

Investigational therapy

Immunotherapy

No prior enzalutamide, abiraterone, or other novel antiandrogen or androgen synthesis inhibitor

No treatment with prior taxane-based chemotherapy for metastatic disease

Patients who received prior taxane-based chemotherapy as neoadjuvant or adjuvant therapy for local disease, or who received taxane-based therapy in the PSA clinical (non-metastatic) state is allowable provided that the total duration of exposure was six cycles or less and chemotherapy was completed more than 6 months prior to registration

Taxane-based chemotherapy that was aborted due to allergic reactions or intolerance to chemotherapy and therefore received 1 cycle of prior therapy is allowable

Patients must have progressive disease at study entry defined as one or more of the following three criteria that occurred while the patient was on androgen deprivation therapy; for patients enrolling on the basis of soft tissue or bone progression, the baseline scan must show progression relative to a comparison scan; if the comparison scan is not available, the baseline scan report must reference the previous scan to document progression

PSA progression defined by a minimum of two rising PSA levels with an interval of >= 1 week between each determination; patients who received an anti-androgen must have progression documented by a minimum of two rising PSA levels with an interval of >=1 week between each determination such that at least the second of these rises is >= 4 weeks since last flutamide or >= 6 weeks since last bicalutamide or nilutamide); the PSA value at the screening should be >= 2 ug/L (2 ng/mL)

Soft tissue disease progression defined by Response Evaluation Criteria in Solid tumors (RECIST) 1.1

Bone disease progression defined by PCWG2 with two or more new lesions on bone scan

All other lesions, including small lesions (longest diameter < 20 mm with conventional techniques or < 10 mm with spiral CT scan) and truly non-measurable lesions; lesions that are considered non-measurable include bone lesions (only)

For lymph nodes to be considered measureable (i.e., target or evaluable lesions), they must be >= 20 mm in at least one dimension, using spiral CT

For visceral or extra-nodal lesions to be considered measurable, they must be >= 10 mm in one dimension, using spiral computed tomography (CT)

Progressive castration-resistant metastatic prostate cancer with histologically or cytologically confirmed adenocarcinoma of the prostate without neuroendocrine differentiation or small cell features

Patients with node only disease (i.e. no presence of visceral, extra nodal lesions or bone lesions) must have node(s) that measure >= 15 mm in short axis

Hemoglobin >= 9 g/dL

Platelet count >= 100,000/uL

Granulocytes >= 1,500/uL

Eastern Cooperative Oncology Group (ECOG) performance status 0-1

No major surgery within 4 weeks prior to enrollment

No gastrointestinal (GI) disorder that negatively affects absorption

No history of seizure or any condition that may increase the patient’s seizure risk (e.g., prior cortical stroke, significant brain trauma); no history of transient ischemic attack (TIA) within 12 months of enrollment

No prior use of ketoconazole for greater than 7 days

Trial Contact Information

Trial Lead Organizations / Sponsors / Collaborators

Alliance for Clinical Trials in Oncology

  • National Cancer Institute
Michael J. Morris, Principal Investigator

Trial Sites

U.S.A.

Alabama
Birmingham

University of Alabama at Birmingham Cancer Center

Guru P. Sonpavde
Ph: 205-934-0309

Guru P. Sonpavde
Principal Investigator

Mobile

Southern Cancer Center PC-Providence

Brian Joseph Heller
Ph: 888-625-6896

Brian Joseph Heller
Principal Investigator

Alaska
Anchorage

Katmai Oncology Group

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Providence Alaska Medical Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Arizona
Scottsdale

Mayo Clinic in Arizona

Alan Haruo Bryce
Ph: 507-538-7623

Alan Haruo Bryce
Principal Investigator

Tucson

The University of Arizona Cancer Center-North Campus

Parminder Singh
Ph: 520-626-9008

Parminder Singh
Principal Investigator

The University of Arizona Cancer Center-Orange Grove Campus

Parminder Singh
Ph: 520-626-9008

Parminder Singh
Principal Investigator

The University of Arizona Medical Center-University Campus

Parminder Singh
Ph: 520-626-9008

Parminder Singh
Principal Investigator

Arkansas
Jonesboro

Fowler Family Center for Cancer Care

Carroll Dean Scroggin
Ph: 870-972-7235

Carroll Dean Scroggin
Principal Investigator

Little Rock

University of Arkansas for Medical Sciences

Konstantinos Arnaoutakis
Ph: 501-686-8274

Konstantinos Arnaoutakis
Principal Investigator

California
Anaheim

Kaiser Permanente-Anaheim

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Antioch

Kaiser Permanente-Deer Valley Medical Center

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Baldwin Park

Kaiser Permanente-Baldwin Park

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Bellflower

Kaiser Permanente-Bellflower

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Duarte

City of Hope Comprehensive Cancer Center

Przemyslaw W. Twardowski
Ph: 800-826-4673
Email: becomingapatient@coh.org

Przemyslaw W. Twardowski
Principal Investigator

Fontana

Kaiser Permanente Hospital

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Fremont

Kaiser Permanente-Fremont

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Fresno

California Cancer Center - North Fresno

Uzair Bashir Chaudhary
Ph: 559-447-4050

Uzair Bashir Chaudhary
Principal Investigator

Kaiser Permanente

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Harbor City

Kaiser Permanente - Harbor City

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Irvine

Kaiser Permanente-Irvine

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

La Jolla

UC San Diego Moores Cancer Center

James Michael Randall
Ph: 858-822-5354
Email: cancercto@ucsd.edu

James Michael Randall
Principal Investigator

Los Angeles

Kaiser Permanente Los Angeles Medical Center

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Kaiser Permanente-Cadillac

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Los Angeles County-USC Medical Center

Amir Goldkorn
Ph: 323-865-0451

Amir Goldkorn
Principal Investigator

USC / Norris Comprehensive Cancer Center

Amir Goldkorn
Ph: 323-865-0451

Amir Goldkorn
Principal Investigator

Modesto

Kaiser Permanente-Modesto

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Newport Beach

USC Norris Oncology/Hematology-Newport Beach

Amir Goldkorn
Ph: 323-865-0451

Amir Goldkorn
Principal Investigator

Oakland

Kaiser Permanente-Oakland

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Orange

UC Irvine Health/Chao Family Comprehensive Cancer Center

John Paul Fruehauf
Ph: 877-827-8839
Email: ucstudy@uci.edu

John Paul Fruehauf
Principal Investigator

Palo Alto

Palo Alto Medical Foundation Health Care

Peter Paul Yu
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Peter Paul Yu
Principal Investigator

Panorama City

Kaiser Permanente - Panorama City

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Paradise

Feather River Cancer Center

Sam Mazj
Ph: 530-876-7995
Email: haleew@ah.org

Sam Mazj
Principal Investigator

Redwood City

Kaiser Permanente-Redwood City

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Richmond

Kaiser Permanente-Richmond

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Riverside

Kaiser Permanente-Riverside

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Roseville

Kaiser Permanente-Roseville

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sacramento

Kaiser Permanente - Sacramento

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Kaiser Permanente-South Sacramento

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

University of California Davis Comprehensive Cancer Center

Primo Nery Lara
Ph: 916-734-3089

Primo Nery Lara
Principal Investigator

San Diego

Kaiser Permanente-San Diego Zion

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Sharp Memorial Hospital

Robert M. Barone
Ph: 858-939-5015

Robert M. Barone
Principal Investigator

San Francisco

Kaiser Permanente-San Francisco

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

UCSF Medical Center-Mount Zion

Terence Ware Friedlander
Ph: 877-827-3222

Terence Ware Friedlander
Principal Investigator

Veterans Affairs Medical Center - San Francisco

Terence Ware Friedlander
Ph: 877-827-3222

Terence Ware Friedlander
Principal Investigator

San Jose

Kaiser Permanente-Santa Teresa-San Jose

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

San Leandro

Kaiser Permanente San Leandro

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

San Rafael

Kaiser Permanente-San Rafael

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Santa Clara

Kaiser Permanente Medical Center - Santa Clara

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Santa Cruz

Palo Alto Medical Foundation-Santa Cruz

Peter Paul Yu
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Peter Paul Yu
Principal Investigator

Santa Rosa

Kaiser Permanente-Santa Rosa

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

South San Francisco

Kaiser Permanente-South San Francisco

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Stockton

Kaiser Permanente-Stockton

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Saint Joseph's Medical Center

Ajithkumar Puthillath
Ph: 209-466-2626

Ajithkumar Puthillath
Principal Investigator

Sunnyvale

Palo Atlo Medical Foundation-Sunnyvale

Peter Paul Yu
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Peter Paul Yu
Principal Investigator

Vacaville

Kaiser Permanente Medical Center-Vacaville

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Vallejo

Kaiser Permanente-Vallejo

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Walnut Creek

Kaiser Permanente-Walnut Creek

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Woodland Hills

Kaiser Permanente

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Colorado
Boulder

Rocky Mountain Cancer Centers-Boulder

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Colorado Springs

Memorial Hospital Colorado Springs

Anthony David Elias
Ph: 720-848-0650

Anthony David Elias
Principal Investigator

Denver

Kaiser Permanente-Franklin

Alexander Menter
Ph: 303-614-1300

Alexander Menter
Principal Investigator

Durango

Southwest Oncology PC

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Fort Collins

Poudre Valley Hospital

Anthony David Elias
Ph: 720-848-0650

Anthony David Elias
Principal Investigator

Lakewood

Rocky Mountain Cancer Centers-Lakewood

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Connecticut
Hartford

Saint Francis Hospital and Medical Center

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Middletown

Middlesex Hospital

Susanna Hong
Ph: 860-358-2058

Susanna Hong
Principal Investigator

Norwalk

Norwalk Hospital

Richard C. Frank
Ph: 203-852-2996
Email: jennifer.long@norwalkhealth.org

Richard C. Frank
Principal Investigator

Norwich

Eastern Connecticut Hematology and Oncology Associates

Dennis E. Slater
Ph: 860-886-8362

Dennis E. Slater
Principal Investigator

West Haven

Veterans Affairs Connecticut Healthcare System-West Haven Campus

Herta Huey-An Chao
Ph: 203-937-3421ext2832

Herta Huey-An Chao
Principal Investigator

District of Columbia
Washington

MedStar Georgetown University Hospital

Nancy Ann Dawson
Ph: 202-444-0381

Nancy Ann Dawson
Principal Investigator

Sibley Memorial Hospital

Emmanuel S. Antonarakis
Ph: 410-955-8804
Email: jhcccro@jhmi.edu

Emmanuel S. Antonarakis
Principal Investigator

Veterans Affairs Medical Center -Washington DC

Anthony Gerard S. Arcenas
Ph: 877-328-2621

Anthony Gerard S. Arcenas
Principal Investigator

Florida
Miami Beach

Mount Sinai Medical Center

Michael A. Schwartz
Ph: 305-674-2625
Email: info@msccop.com

Michael A. Schwartz
Principal Investigator

Orlando

Florida Hospital Orlando

Lee M. Zehngebot
Ph: 407-303-5623

Lee M. Zehngebot
Principal Investigator

Pensacola

Sacred Heart Hospital

James F. Watkins
Ph: 850-416-4611
Email: ttamayo@shhpens.org

James F. Watkins
Principal Investigator

Georgia
Atlanta

Northside Hospital

Pradeep Jolly
Ph: 404-303-3355

Pradeep Jolly
Principal Investigator

Decatur

Atlanta VA Medical Center

Wayne Bernard Harris
Ph: 404-778-1868

Wayne Bernard Harris
Principal Investigator

Savannah

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler

Mark Alexander Taylor
Ph: 912-350-8568

Mark Alexander Taylor
Principal Investigator

Hawaii
Aiea

Oncare Hawaii Inc-Pali Momi

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Pali Momi Medical Center

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Honolulu

Island Urology

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Kaiser Permanente Moanalua Medical Center

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Kuakini Medical Center

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Oncare Hawaii Inc-Kuakini

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Oncare Hawaii Inc-POB II

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Queen's Medical Center

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Straub Clinic and Hospital

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

University of Hawaii Cancer Center

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Lihue

Wilcox Memorial Hospital and Kauai Medical Clinic

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Idaho
Boise

Saint Alphonsus Cancer Care Center-Boise

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Post Falls

Kootenai Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Illinois
Chicago

Advocate Illinois Masonic Medical Center

Mebea Aklilu
Ph: 773-296-5360

Mebea Aklilu
Principal Investigator

Decatur

Cancer Care Center of Decatur

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Decatur Memorial Hospital

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Effingham

Crossroads Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Evanston

NorthShore University HealthSystem-Evanston Hospital

Daniel H. Shevrin
Ph: 847-570-2109

Daniel H. Shevrin
Principal Investigator

Glenview

NorthShore University HealthSystem-Glenbrook Hospital

Daniel H. Shevrin
Ph: 847-570-2109

Daniel H. Shevrin
Principal Investigator

Harvey

Ingalls Memorial Hospital

Mark Farrell Kozloff
Ph: 708-915-4673
Email: clinicaltrials@ingalls.org

Mark Farrell Kozloff
Principal Investigator

Highland Park

NorthShore University HealthSystem-Highland Park Hospital

Daniel H. Shevrin
Ph: 847-570-2109

Daniel H. Shevrin
Principal Investigator

Maywood

Loyola University Medical Center

Elizabeth Henry
Ph: 708-226-4357

Elizabeth Henry
Principal Investigator

Peoria

Illinois CancerCare-Peoria

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Quincy

Quincy Medical Group-Clinic

Raymond P. Smith
Ph: 888-823-5923
Email: ctsucontact@westat.com

Raymond P. Smith
Principal Investigator

Rockford

Saint Anthony Medical Center

Shylendra B. Sreenivasappa
Ph: 815-227-2633

Shylendra B. Sreenivasappa
Principal Investigator

Springfield

Memorial Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Urbana

Carle Cancer Center

Vamsi Krishna Vasireddy
Ph: 800-446-5532

Vamsi Krishna Vasireddy
Principal Investigator

Warrenville

Cadence Cancer Center in Warrenville

Robert Michael Eisner
Ph: 630-352-5300

Robert Michael Eisner
Principal Investigator

Indiana
Fort Wayne

Fort Wayne Medical Oncology and Hematology Inc-Parkview

Sreenivasa R. Nattam
Ph: 260-484-8830
Email: ledgar@fwmoh.com

Sreenivasa R. Nattam
Principal Investigator

Mishawaka

Michiana Hematology Oncology PC-Mishawaka

Robin T. Zon
Ph: 574-234-5123

Robin T. Zon
Principal Investigator

Munster

The Community Hospital

Mohamad Kassar
Ph: 219-836-3349

Mohamad Kassar
Principal Investigator

South Bend

Memorial Hospital of South Bend

Thomas Joseph Reid
Ph: 800-284-7370

Thomas Joseph Reid
Principal Investigator

Westville

Michiana Hematology Oncology-PC Westville

Robin T. Zon
Ph: 574-234-5123

Robin T. Zon
Principal Investigator

Iowa
Ames

McFarland Clinic PC-William R Bliss Cancer Center

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Bettendorf

Hematology Oncology Associates-Quad Cities

Shobha R. Chitneni
Ph: 563-355-7733
Email: kedaprile@rccqc.com

Shobha R. Chitneni
Principal Investigator

Clive

Medical Oncology and Hematology Associates-West Des Moines

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Mercy Cancer Center-West Lakes

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Davenport

Genesis Medical Center - East Campus

George Kovach
Ph: 800-446-6088
Email: werners@genesishealth.com

George Kovach
Principal Investigator

Des Moines

Medical Oncology and Hematology Associates-Laurel

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Mercy Medical Center - Des Moines

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Iowa City

Iowa City VA Healthcare System

Laith Abushahin
Ph: 800-237-1225

Laith Abushahin
Principal Investigator

University of Iowa/Holden Comprehensive Cancer Center

Daniel Alberto Vaena
Ph: 800-237-1225

Daniel Alberto Vaena
Principal Investigator

Mason City

Mercy Medical Center - North Iowa

Arvind Y. Vemula
Ph: 800-433-3883

Arvind Y. Vemula
Principal Investigator

Sioux City

Siouxland Regional Cancer Center

Donald B. Wender
Ph: 712-252-0088

Donald B. Wender
Principal Investigator

West Des Moines

Mercy Medical Center-West Lakes

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Kansas
Emporia

Newman Regional Health

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Garden City

Saint Catherine Hospital

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Great Bend

Saint Rose Ambulatory and Surgery Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Hays

Hays Medical Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Kansas City

Kansas City Cancer Center-West

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

University of Kansas Cancer Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Olathe

Olathe Medical Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Overland Park

Kansas City Cancer Centers-Southwest

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Saint Luke's South Hospital

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Rakesh Gaur
Principal Investigator

Pittsburg

Via Christi Hospital-Pittsburg

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Salina

Salina Regional Health Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Topeka

Saint Francis Hospital and Medical Center - Topeka

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Louisiana
Alexandria

Christus Saint Frances Cabrini Hospital

Steven J. Saccaro
Ph: 504-988-6121

Steven J. Saccaro
Principal Investigator

Baton Rouge

Ochsner Health Center-Summa

Marc R. Matrana
Ph: 888-562-4763

Marc R. Matrana
Principal Investigator

Kenner

Ochsner Medical Center Kenner

Marc R. Matrana
Ph: 888-562-4763

Marc R. Matrana
Principal Investigator

New Orleans

Ochsner Medical Center Jefferson

Marc R. Matrana
Ph: 888-562-4763

Marc R. Matrana
Principal Investigator

Tulane University Health Sciences Center

Hana F. Safah
Ph: 504-988-6121

Hana F. Safah
Principal Investigator

Maine
Augusta

Harold Alfond Center for Cancer Care

Thomas H. Openshaw
Ph: 207-973-4274

Thomas H. Openshaw
Principal Investigator

Rockport

Penobscot Bay Medical Center

Thomas H. Openshaw
Ph: 207-973-4274

Thomas H. Openshaw
Principal Investigator

Maryland
Baltimore

Johns Hopkins University/Sidney Kimmel Cancer Center

Emmanuel S. Antonarakis
Ph: 410-955-8804
Email: jhcccro@jhmi.edu

Emmanuel S. Antonarakis
Principal Investigator

Frederick

Frederick Memorial Hospital

Elhamy D. Eskander
Ph: 240-566-3584
Email: clinicaltrials@fmh.org

Elhamy D. Eskander
Principal Investigator

Olney

Montgomery General Hospital-Olney

Nancy Ann Dawson
Ph: 202-444-0381

Nancy Ann Dawson
Principal Investigator

Westminster

Carroll Hospital Center/Kahlert Regional Cancer Center

Flavio Wainberg Kruter
Ph: 888-823-5923
Email: ctsucontact@westat.com

Flavio Wainberg Kruter
Principal Investigator

Massachusetts
Boston

Tufts Medical Center

Paul Mathew
Ph: 617-636-5000
Email: ContactUsCancerCenter@TuftsMedicalCenter.org

Paul Mathew
Principal Investigator

Newton

Newton-Wellesley Hospital

Caroline Cole Block
Ph: 888-823-5923
Email: ctsucontact@westat.com

Caroline Cole Block
Principal Investigator

Springfield

Baystate Medical Center

Leslie Marion Howard
Ph: 413-794-3565
Email: tamara.wrenn@baystatehealth.org

Leslie Marion Howard
Principal Investigator

Michigan
Ann Arbor

Saint Joseph Mercy Hospital

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Detroit

Henry Ford Hospital

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Wayne State University/Karmanos Cancer Institute

Ulka N. Vaishampayan
Ph: 313-576-9363

Ulka N. Vaishampayan
Principal Investigator

Escanaba

Green Bay Oncology - Escanaba

Anthony John Jaslowski
Ph: 800-432-6049

Anthony John Jaslowski
Principal Investigator

Grand Rapids

Mercy Health Saint Mary's

Gilbert D.A. Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Gilbert D.A. Padula
Principal Investigator

Spectrum Health at Butterworth Campus

Gilbert D.A. Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Gilbert D.A. Padula
Principal Investigator

Iron Mountain

Green Bay Oncology - Iron Mountain

Anthony John Jaslowski
Ph: 800-432-6049

Anthony John Jaslowski
Principal Investigator

Lansing

Sparrow Hospital

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Livonia

Saint Mary Mercy Hospital

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Reed City

Spectrum Health Reed City Hospital

Gilbert D.A. Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Gilbert D.A. Padula
Principal Investigator

Saginaw

Saint Mary's of Michigan

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Traverse City

Munson Medical Center

Gilbert D.A. Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Gilbert D.A. Padula
Principal Investigator

Minnesota
Bemidji

Sanford Clinic North-Bemidgi

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Coon Rapids

Mercy Hospital

Daniel M. Anderson
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Daniel M. Anderson
Principal Investigator

Duluth

Essentia Health Cancer Center

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Saint Luke's Hospital of Duluth

Basem Said Goueli
Ph: 888-823-5923
Email: ctsucontact@westat.com

Basem Said Goueli
Principal Investigator

Fridley

Unity Hospital

Daniel M. Anderson
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Daniel M. Anderson
Principal Investigator

Maplewood

Saint John's Hospital - Healtheast

Daniel M. Anderson
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Daniel M. Anderson
Principal Investigator

Minneapolis

Hennepin County Medical Center

Daniel M. Anderson
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Daniel M. Anderson
Principal Investigator

Minneapolis Veterans Medical Center

Sharon Davis Luikart
Ph: 612-467-2800

Sharon Davis Luikart
Principal Investigator

Saint Cloud

Coborn Cancer Center at Saint Cloud Hospital

Donald James Jurgens
Ph: 877-229-4907
Email: coborncancercenter@centracare.com

Donald James Jurgens
Principal Investigator

Saint Louis Park

Park Nicollet Clinic - Saint Louis Park

Daniel M. Anderson
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Daniel M. Anderson
Principal Investigator

Saint Paul

Regions Hospital

Daniel M. Anderson
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Daniel M. Anderson
Principal Investigator

Shakopee

Saint Francis Regional Medical Center

Daniel M. Anderson
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Daniel M. Anderson
Principal Investigator

Stillwater

Lakeview Hospital

Daniel M. Anderson
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Daniel M. Anderson
Principal Investigator

Woodbury

Minnesota Oncology and Hematology PA-Woodbury

Daniel M. Anderson
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Daniel M. Anderson
Principal Investigator

Missouri
Cape Girardeau

Saint Francis Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Southeast Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Chesterfield

Saint Luke's Hospital

Donald F. Busiek
Ph: 314-205-6936

Donald F. Busiek
Principal Investigator

Columbia

University of Missouri - Ellis Fischel

Clint Daniel Kingsley
Ph: 573-882-7440

Clint Daniel Kingsley
Principal Investigator

Kansas City

Kansas City Cancer Center - South

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Kansas City Cancer Centers - North

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Kansas City Veterans Affairs Medical Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Research Medical Center

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Rakesh Gaur
Principal Investigator

Saint Luke's Hospital of Kansas City

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Rakesh Gaur
Principal Investigator

Truman Medical Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Lee's Summit

Kansas City Cancer Center-Lee's Summit

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Saint Luke's East - Lee's Summit

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Rakesh Gaur
Principal Investigator

Saint Louis

Barnes-Jewish West County Hospital

Joel Picus
Ph: 800-600-3606
Email: info@siteman.wustl.edu

Joel Picus
Principal Investigator

Mercy Hospital Saint Louis

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Missouri Baptist Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Washington University School of Medicine

Joel Picus
Ph: 800-600-3606
Email: info@siteman.wustl.edu

Joel Picus
Principal Investigator

Springfield

Mercy Hospital Springfield

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Montana
Billings

Saint Vincent Healthcare

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Bozeman

Bozeman Deaconess Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Butte

Saint James Community Hospital and Cancer Treatment Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Nebraska
Grand Island

CHI Health Saint Francis

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Kearney

CHI Health Good Samaritan

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Lincoln

Nebraska Hematology and Oncology

Gamini S. Soori
Ph: 402-991-8070
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

Southeast Nebraska Cancer Center

Gamini S. Soori
Ph: 402-991-8070
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

Omaha

Nebraska Methodist Hospital

Ralph J. Hauke
Ph: 402-354-5144

Ralph J. Hauke
Principal Investigator

Nevada
Las Vegas

HealthCare Partners Medical Group Oncology/Hematology-San Martin

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Tenaya

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

New Hampshire
Concord

New Hampshire Oncology Hematology PA-Concord

Frederick M. Briccetti
Ph: 800-339-6484

Frederick M. Briccetti
Principal Investigator

Dover

Wentworth-Douglass Hospital

Taylor M. Ortiz
Ph: 603-740-2150

Taylor M. Ortiz
Principal Investigator

Hooksett

New Hampshire Oncology Hematology PA-Hooksett

Frederick M. Briccetti
Ph: 800-339-6484

Frederick M. Briccetti
Principal Investigator

Laconia

LRGHealthcare-Lakes Region General Hospital

Frederick M. Briccetti
Ph: 800-339-6484

Frederick M. Briccetti
Principal Investigator

Lebanon

Dartmouth Hitchcock Medical Center

Sergey Devitskiy
Ph: 800-639-6918
Email: cancer.research.nurse@dartmouth.edu

Sergey Devitskiy
Principal Investigator

Portsmouth

Portsmouth Regional Hospital

Christine Wasilewski
Ph: 603-433-5226

Christine Wasilewski
Principal Investigator

New Jersey
Basking Ridge

Memorial Sloan Kettering Cancer Center at Basking Ridge

Michael J. Morris
Ph: 212-639-7202

Michael J. Morris
Principal Investigator

East Orange

Veterans Adminstration New Jersey Health Care System

Victor Tsu-Shih Chang
Ph: 800-475-2336
Email: patricia.goyer@med.va.gov

Victor Tsu-Shih Chang
Principal Investigator

Hackensack

Hackensack University Medical Center

Samuel A. Goldlust
Ph: 201-996-2879

Samuel A. Goldlust
Principal Investigator

Mount Holly

Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County

James W. Lee
Ph: 888-847-8823

James W. Lee
Principal Investigator

Paramus

The Valley Hospital-Luckow Pavilion

Eli D. Kirshner
Ph: 201-634-5792

Eli D. Kirshner
Principal Investigator

Voorhees

Virtua West Jersey Hospital Voorhees

James W. Lee
Ph: 888-847-8823

James W. Lee
Principal Investigator

Westwood

Oncology Hematology and Internal Medicine

Eli D. Kirshner
Ph: 201-634-5792

Eli D. Kirshner
Principal Investigator

New Mexico
Albuquerque

University of New Mexico

Richard C. Lauer
Ph: 505-272-6972

Richard C. Lauer
Principal Investigator

Las Cruces

Memorial Medical Center - Las Cruces

Richard C. Lauer
Ph: 505-272-6972

Richard C. Lauer
Principal Investigator

Santa Fe

Christus Saint Vincent Regional Cancer Center

Richard C. Lauer
Ph: 505-272-6972

Richard C. Lauer
Principal Investigator

New York
Bronx

Bronx Veterans Administration Medical Center

Yeun-Hee Anna Park
Ph: 212-305-8615

Yeun-Hee Anna Park
Principal Investigator

Montefiore Medical Center - Moses Campus

Benjamin Adam Gartrell
Ph: 718-904-2730
Email: aecc@aecom.yu.edu

Benjamin Adam Gartrell
Principal Investigator

Montefiore Medical Center-Einstein Campus

Benjamin Adam Gartrell
Ph: 718-904-2730
Email: aecc@aecom.yu.edu

Benjamin Adam Gartrell
Principal Investigator

Brooklyn

Kings County Hospital

Jason Parker Gonsky
Ph: 718-245-3131

Jason Parker Gonsky
Principal Investigator

Maimonides Medical Center

Kevin Becker
Ph: 718-765-2500

Kevin Becker
Principal Investigator

Buffalo

Roswell Park Cancer Institute

Saby George
Ph: 877-275-7724

Saby George
Principal Investigator

Veterans Affairs Western New York Health Care System-Buffalo

Lynn M. Steinbrenner
Ph: 716-862-3191

Lynn M. Steinbrenner
Principal Investigator

Commack

Memorial Sloan Kettering Cancer Center Commack

Michael J. Morris
Ph: 212-639-7202

Michael J. Morris
Principal Investigator

Elmira

Arnot Ogden Medical Center/Falck Cancer Center

William Thomas Muuse
Ph: 607-271-7000

William Thomas Muuse
Principal Investigator

New Hyde Park

North Shore-LIJ Health System/Center for Advanced Medicine

Xinhua Zhu
Ph: 516-562-3467

Xinhua Zhu
Principal Investigator

New York

Columbia University Medical Center

Emerson A. Lim
Ph: 212-305-8615

Emerson A. Lim
Principal Investigator

Laura and Issac Perlmutter Cancer Center at NYU Langone

Anna C. Ferrari
Ph: 212-263-4434
Email: prmc.coordinator@nyumc.org

Anna C. Ferrari
Principal Investigator

Memorial Sloan-Kettering Cancer Center

Michael J. Morris
Ph: 212-639-7202

Michael J. Morris
Principal Investigator

Weill Medical College of Cornell University

Scott Tadashi Tagawa
Ph: 212-746-1848

Scott Tadashi Tagawa
Principal Investigator

Rochester

University of Rochester

Jonathan Willmann Friedberg
Ph: 585-275-5830

Jonathan Willmann Friedberg
Principal Investigator

Rockville Centre

Memorial Sloan-Kettering Cancer Center Rockville Centre

Michael J. Morris
Ph: 212-639-7202

Michael J. Morris
Principal Investigator

Sleepy Hollow

Memorial Sloan-Kettering Cancer Center Sleepy Hollow

Michael J. Morris
Ph: 212-639-7202

Michael J. Morris
Principal Investigator

Stony Brook

Stony Brook University Medical Center

Shenhong Wu
Ph: 800-862-2215

Shenhong Wu
Principal Investigator

Syracuse

State University of New York Upstate Medical University

Sam Benjamin
Ph: 315-464-5476

Sam Benjamin
Principal Investigator

Syracuse Veterans Administration Medical Center

Namita Chittoria
Ph: 315-425-2707

Namita Chittoria
Principal Investigator

West Harrison

Memorial Sloan-Kettering Cancer Center West Harrison

Michael J. Morris
Ph: 212-639-7202

Michael J. Morris
Principal Investigator

North Carolina
Asheboro

Randolph Hospital

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Chapel Hill

University of North Carolina at Chapel Hill

Young E. Whang
Ph: 877-668-0683
Email: cancerclinicaltrials@med.unc.edu

Young E. Whang
Principal Investigator

Charlotte

Novant Health Presbyterian Medical Center

Justin Peter Favaro
Ph: 704-384-5369

Justin Peter Favaro
Principal Investigator

Oncology Specialists of Charlotte

Justin Peter Favaro
Ph: 704-384-5369

Justin Peter Favaro
Principal Investigator

Southern Oncology Specialists-Charlotte

Justin Peter Favaro
Ph: 704-384-5369

Justin Peter Favaro
Principal Investigator

Durham

Duke University Medical Center

Jeffrey Crawford
Ph: 888-275-3853

Jeffrey Crawford
Principal Investigator

Durham Veterans Affairs Medical Center

Daphne R. Friedman
Ph: 919-286-6926
Email: John.Whited@va.gov

Daphne R. Friedman
Principal Investigator

Goldsboro

Wayne Memorial Hospital

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Greensboro

Cone Health Cancer Center

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Huntersville

Lake Norman Hematology Oncology Specialists-Huntersville

Justin Peter Favaro
Ph: 704-384-5369

Justin Peter Favaro
Principal Investigator

Southern Oncology Specialists-Huntersville

Justin Peter Favaro
Ph: 704-384-5369

Justin Peter Favaro
Principal Investigator

Kernersville

Novant Health Oncology Specialists-Kernersville

Timothy Scott Collins
Ph: 336-277-8887

Timothy Scott Collins
Principal Investigator

Kinston

Kinston Medical Specialists PA

Peter Robins Watson
Ph: 252-559-2200

Peter Robins Watson
Principal Investigator

Lexington

Novant Health Oncology Specialists-Davidson County

Timothy Scott Collins
Ph: 336-277-8887

Timothy Scott Collins
Principal Investigator

Matthews

Matthews Hematology and Oncology

Justin Peter Favaro
Ph: 704-384-5369

Justin Peter Favaro
Principal Investigator

Mooresville

Lake Norman Hematology Oncology Specialists-Mooresville

Justin Peter Favaro
Ph: 704-384-5369

Justin Peter Favaro
Principal Investigator

Mount Airy

Novant Health Oncology Specialists-Mount Airy

Timothy Scott Collins
Ph: 336-277-8887

Timothy Scott Collins
Principal Investigator

Reidsville

Annie Penn Memorial Hospital

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Salisbury

Carolina Oncology Associates PA

Timothy Scott Collins
Ph: 336-277-8887

Timothy Scott Collins
Principal Investigator

Stateville

Novant Health Oncology Specialists-Statesville

Timothy Scott Collins
Ph: 336-277-8887

Timothy Scott Collins
Principal Investigator

Washington

Marion L Shepard Cancer Center at Vidant Beaufort Hospital

John Joseph Inzerillo
Ph: 252-975-4308

John Joseph Inzerillo
Principal Investigator

Wilkesboro

Novant Health Oncology Specialists-Wilkesboro

Timothy Scott Collins
Ph: 336-277-8887

Timothy Scott Collins
Principal Investigator

Winston-Salem

Novant Health Forsyth Medical Center

Timothy Scott Collins
Ph: 336-277-8887

Timothy Scott Collins
Principal Investigator

Novant Health Oncology Specialists

Timothy Scott Collins
Ph: 336-277-8887

Timothy Scott Collins
Principal Investigator

Wake Forest University Health Sciences

Rhonda Lynn Bitting
Ph: 336-713-6771

Rhonda Lynn Bitting
Principal Investigator

Winston-Salem Health Care

Timothy Scott Collins
Ph: 336-277-8887

Timothy Scott Collins
Principal Investigator

North Dakota
Bismarck

Sanford Bismarck Medical Center

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Fargo

Sanford Clinic North-Fargo

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford Medical Center-Fargo

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Grand Forks

Altru Cancer Center

Grant Richard Seeger
Ph: 701-780-6520

Grant Richard Seeger
Principal Investigator

Minot

Trinity Cancer Care Center

Patanit Watanaboonyakhet
Ph: 800-862-0005

Patanit Watanaboonyakhet
Principal Investigator

Ohio
Akron

Summa Akron City Hospital/Cooper Cancer Center

Jennifer Eileen Payne
Ph: 330-375-6101

Jennifer Eileen Payne
Principal Investigator

Barberton

Summa Barberton Hospital

Jennifer Eileen Payne
Ph: 330-375-6101

Jennifer Eileen Payne
Principal Investigator

Beachwood

UHHS-Chagrin Highlands Medical Center

Matthew Morrissey Cooney
Ph: 800-641-2422

Matthew Morrissey Cooney
Principal Investigator

Chardon

Geaugra Hospital

Matthew Morrissey Cooney
Ph: 800-641-2422

Matthew Morrissey Cooney
Principal Investigator

Cincinnati

University of Cincinnati

Neetu Radhakrishnan
Ph: 513-558-4553
Email: uchealthnews@uc.edu

Neetu Radhakrishnan
Principal Investigator

Cleveland

Case Western Reserve University

Matthew Morrissey Cooney
Ph: 800-641-2422

Matthew Morrissey Cooney
Principal Investigator

Cleveland Clinic Cancer Center/Fairview Hospital

Anjali S. Advani
Ph: 866-223-8100

Anjali S. Advani
Principal Investigator

Cleveland Clinic Foundation

Anjali S. Advani
Ph: 866-223-8100

Anjali S. Advani
Principal Investigator

MetroHealth Medical Center

Bruce J. Averbook
Ph: 216-778-8526
Email: kbauchens@metrohealth.org

Bruce J. Averbook
Principal Investigator

Columbus

Ohio State University Comprehensive Cancer Center

Amir Mortazavi
Ph: 800-293-5066
Email: Jamesline@osumc.edu

Amir Mortazavi
Principal Investigator

Elyria

Hematology Oncology Center Incorporated

Matthew Morrissey Cooney
Ph: 800-641-2422

Matthew Morrissey Cooney
Principal Investigator

Independence

Cleveland Clinic Cancer Center Independence

Anjali S. Advani
Ph: 866-223-8100

Anjali S. Advani
Principal Investigator

Mansfield

Cleveland Clinic Cancer Center Mansfield

Anjali S. Advani
Ph: 866-223-8100

Anjali S. Advani
Principal Investigator

Mayfield Heights

Hillcrest Hospital Cancer Center

Anjali S. Advani
Ph: 866-223-8100

Anjali S. Advani
Principal Investigator

Ireland Cancer Center Landerbrook Health Center

Matthew Morrissey Cooney
Ph: 800-641-2422

Matthew Morrissey Cooney
Principal Investigator

Medina

Summa Health Center at Lake Medina

Jennifer Eileen Payne
Ph: 330-375-6101

Jennifer Eileen Payne
Principal Investigator

Mentor

Lake University Ireland Cancer Center

Matthew Morrissey Cooney
Ph: 800-641-2422

Matthew Morrissey Cooney
Principal Investigator

Middleburg Heights

Southwest General Health Center Ireland Cancer Center

Matthew Morrissey Cooney
Ph: 800-641-2422

Matthew Morrissey Cooney
Principal Investigator

Sandusky

Ireland Cancer Center at Firelands Regional Medical Center

Matthew Morrissey Cooney
Ph: 800-641-2422

Matthew Morrissey Cooney
Principal Investigator

North Coast Cancer Care

Anjali S. Advani
Ph: 866-223-8100

Anjali S. Advani
Principal Investigator

Strongsville

Cleveland Clinic Cancer Center Strongsville

Anjali S. Advani
Ph: 866-223-8100

Anjali S. Advani
Principal Investigator

Wadsworth

University Hospitals Sharon Health Center

Matthew Morrissey Cooney
Ph: 800-641-2422

Matthew Morrissey Cooney
Principal Investigator

Warrensville Heights

South Pointe Hospital

Anjali S. Advani
Ph: 866-223-8100

Anjali S. Advani
Principal Investigator

West Chester

University Pointe

Neetu Radhakrishnan
Ph: 513-558-4553
Email: uchealthnews@uc.edu

Neetu Radhakrishnan
Principal Investigator

Westlake

UHHS-Westlake Medical Center

Matthew Morrissey Cooney
Ph: 800-641-2422

Matthew Morrissey Cooney
Principal Investigator

UH-Seidman Cancer Center at Saint John Medical Center

Matthew Morrissey Cooney
Ph: 800-641-2422

Matthew Morrissey Cooney
Principal Investigator

Wooster

Cleveland Clinic Wooster Specialty Center

Anjali S. Advani
Ph: 866-223-8100

Anjali S. Advani
Principal Investigator

Oklahoma
Lawton

Cancer Centers of Southwest Oklahoma Research

Nadim Fouad Nimeh
Ph: 877-231-4440

Nadim Fouad Nimeh
Principal Investigator

Oklahoma City

University of Oklahoma Health Sciences Center

Sindhu Singh
Ph: 405-271-4272
Email: julie-traylor@ouhsc.edu

Sindhu Singh
Principal Investigator

Tulsa

Tulsa Cancer Institute

Sindhu Singh
Ph: 405-271-4272
Email: julie-traylor@ouhsc.edu

Sindhu Singh
Principal Investigator

Oregon
Corvallis

Good Samaritan Hospital

Kimberly A. McGregor
Ph: 888-823-5923
Email: ctsucontact@westat.com

Kimberly A. McGregor
Principal Investigator

Newberg

Providence Newberg Medical Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Oregon City

Providence Willamette Falls Medical Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Portland

Kaiser Permanente

Nagendra Ranganatha Tirumali
Ph: 503-335-2400

Nagendra Ranganatha Tirumali
Principal Investigator

Legacy Good Samaritan Hospital and Medical Center

Regan Mon Look
Ph: 503-280-1223

Regan Mon Look
Principal Investigator

Providence Portland Medical Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Pennsylvania
Allentown

Lehigh Valley Hospital-Cedar Crest

Suresh G. Nair
Ph: 610-402-2273

Suresh G. Nair
Principal Investigator

Bethlehem

Lehigh Valley Hospital - Muhlenberg

Suresh G. Nair
Ph: 610-402-2273

Suresh G. Nair
Principal Investigator

Gettysburg

Adams Cancer Center

Amir Tabatabai
Ph: 877-441-7957

Amir Tabatabai
Principal Investigator

Langhorne

Saint Mary Medical and Regional Cancer Center

Robert E. Reilly
Ph: 215-710-4585

Robert E. Reilly
Principal Investigator

Natrona Heights

Allegheny Valley Hospital

Shifeng Stefan Mao
Ph: 877-284-2000

Shifeng Stefan Mao
Principal Investigator

Pittsburgh

Allegheny General Hospital

Shifeng Stefan Mao
Ph: 877-284-2000

Shifeng Stefan Mao
Principal Investigator

University of Pittsburgh Cancer Institute (UPCI)

Leonard Joseph Appleman
Ph: 412-647-8073

Leonard Joseph Appleman
Principal Investigator

York

WellSpan Health-York Hospital

Amir Tabatabai
Ph: 877-441-7957

Amir Tabatabai
Principal Investigator

PR
San Juan

Fundacion De Investigacion de Diego

Deana Hallman Navarro
Ph: 787-765-2363

Deana Hallman Navarro
Principal Investigator

South Carolina
Charleston

Bon Secours Saint Francis Hospital

James Michael Orcutt
Ph: 843-720-8386
Email: elizabeth.strojny@roperstfrancis.com

James Michael Orcutt
Principal Investigator

Charleston Hematology Oncology Associates PA-St. Francis

James Michael Orcutt
Ph: 843-720-8386
Email: elizabeth.strojny@roperstfrancis.com

James Michael Orcutt
Principal Investigator

Charleston Hematology Oncology Associates-Roper

James Michael Orcutt
Ph: 843-720-8386
Email: elizabeth.strojny@roperstfrancis.com

James Michael Orcutt
Principal Investigator

Lowcountry Hematology Oncology PA-West Ashley

James Michael Orcutt
Ph: 843-720-8386
Email: elizabeth.strojny@roperstfrancis.com

James Michael Orcutt
Principal Investigator

Roper Hospital

James Michael Orcutt
Ph: 843-720-8386
Email: elizabeth.strojny@roperstfrancis.com

James Michael Orcutt
Principal Investigator

Easley

Greenville Health System Cancer Institute-Easley

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville

Greenville Health System Cancer Institute-Butternut

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Health System Cancer Institute-Eastside

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Health System Cancer Institute-Faris

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Saint Francis Hospital

James Dewitt Bearden
Ph: 800-486-5941

James Dewitt Bearden
Principal Investigator

Greer

Greenville Health System Cancer Institute-Greer

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Mount Pleasant

Lowcountry Hematology Oncology PA-Mount Pleasant

James Michael Orcutt
Ph: 843-720-8386
Email: elizabeth.strojny@roperstfrancis.com

James Michael Orcutt
Principal Investigator

Seneca

Greenville Health System Cancer Institute-Seneca

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Spartanburg

Greenville Health System Cancer Institute-Spartanburg

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

South Dakota
Aberdeen

Avera Saint Luke's Hospital and Cancer Center

Amy K. Krie
Ph: 800-657-4377
Email: Jan.Healy@avera.org

Amy K. Krie
Principal Investigator

Rapid City

Rapid City Regional Hospital

Joshua Cole Lukenbill
Ph: 605-716-3982
Email: research@rcrh.org

Joshua Cole Lukenbill
Principal Investigator

Sioux Falls

Avera Cancer Institute

Amy K. Krie
Ph: 800-657-4377
Email: Jan.Healy@avera.org

Amy K. Krie
Principal Investigator

Sanford Cancer Center-Oncology Clinic

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Tennessee
Memphis

University of Tennessee Health Science Center

Bradley G. Somer
Ph: 901-448-3303

Bradley G. Somer
Principal Investigator

Texas
Dallas

UT Southwestern/Simmons Cancer Center-Dallas

Kevin Dale Courtney
Ph: 214-648-7097

Kevin Dale Courtney
Principal Investigator

Houston

Baylor College of Medicine

Aihua Edward Yen
Ph: 713-798-1354
Email: burton@bcm.edu

Aihua Edward Yen
Principal Investigator

Ben Taub General Hospital

Aihua Edward Yen
Ph: 713-798-1354
Email: burton@bcm.edu

Aihua Edward Yen
Principal Investigator

Vermont
Burlington

University of Vermont College of Medicine

Steven Ades
Ph: 802-656-4101

Steven Ades
Principal Investigator

Virginia
Hampton

Virginia Oncology Associates-Hampton

Paul R. Conkling
Ph: 757-873-9400

Paul R. Conkling
Principal Investigator

Lynchburg

Lynchburg Hematology-Oncology Clinic

Hetal R. Vachhani
Ph: 804-628-1939

Hetal R. Vachhani
Principal Investigator

Midlothian

Bon Secours Saint Francis Medical Center

William Johnson Irvin
Ph: 804-594-4900

William Johnson Irvin
Principal Investigator

Richmond

Virginia Cancer Institute

Hetal R. Vachhani
Ph: 804-628-1939

Hetal R. Vachhani
Principal Investigator

Virginia Commonwealth University/Massey Cancer Center

Hetal R. Vachhani
Ph: 804-628-1939

Hetal R. Vachhani
Principal Investigator

Winchester

Shenandoah Oncology Associates PC

Hetal R. Vachhani
Ph: 804-628-1939

Hetal R. Vachhani
Principal Investigator

Washington
Bellingham

PeaceHealth Saint Joseph Medical Center

Gary E. Goodman
Ph: 206-386-2323
Email: patra.grevstad@swedish.org

Gary E. Goodman
Principal Investigator

Issaquah

Swedish Cancer Institute-Issaquah

Gary E. Goodman
Ph: 206-386-2323
Email: patra.grevstad@swedish.org

Gary E. Goodman
Principal Investigator

Poulsbo

Harrison HealthPartners Hematology and Oncology-Poulsbo

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Seattle

Minor and James Medical PLLC

Gary E. Goodman
Ph: 206-386-2323
Email: patra.grevstad@swedish.org

Gary E. Goodman
Principal Investigator

Swedish Medical Center-First Hill

Gary E. Goodman
Ph: 206-386-2323
Email: patra.grevstad@swedish.org

Gary E. Goodman
Principal Investigator

West Virginia
Huntington

Saint Mary's Medical Center

Arvinder Singh Bir
Ph: 888-823-5923
Email: ctsucontact@westat.com

Arvinder Singh Bir
Principal Investigator

Wisconsin
Antigo

Langlade Hospital and Cancer Center

Christopher Gary Peterson
Ph: 877-405-6866

Christopher Gary Peterson
Principal Investigator

Burlington

Aurora Cancer Care-Burlington

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Eau Claire

Marshfield Clinic Cancer Center at Sacred Heart

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Sacred Heart Hospital

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Elkhorn

Aurora Cancer Care-Southern Lakes

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Fond Du Lac

Saint Agnes Hospital/Agnesian Cancer Center

Filip T. Troicki
Ph: 800-494-2927

Filip T. Troicki
Principal Investigator

Grafton

Aurora Cancer Care-Grafton

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Green Bay

Aurora BayCare Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Green Bay Oncology at Saint Vincent Hospital

Anthony John Jaslowski
Ph: 800-432-6049

Anthony John Jaslowski
Principal Investigator

Green Bay Oncology Limited at Saint Mary's Hospital

Anthony John Jaslowski
Ph: 800-432-6049

Anthony John Jaslowski
Principal Investigator

Saint Mary's Hospital

Anthony John Jaslowski
Ph: 800-432-6049

Anthony John Jaslowski
Principal Investigator

Saint Vincent Hospital

Anthony John Jaslowski
Ph: 800-432-6049

Anthony John Jaslowski
Principal Investigator

Kenosha

Aurora Cancer Care-Kenosha South

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

La Crosse

Gundersen Lutheran Medical Center

Michael O Ojelabi
Ph: 608-775-2385
Email: cancerctr@gundluth.org

Michael O Ojelabi
Principal Investigator

Manitowoc

Holy Family Memorial Hospital

Anthony John Jaslowski
Ph: 800-432-6049

Anthony John Jaslowski
Principal Investigator

Marinette

Vince Lombardi Cancer Clinic-Marinette

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Marshfield

Marshfield Clinic

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Saint Joseph's Hospital

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Menomonee Falls

Aurora Advanced Healthcare Inc-Menomonee Falls

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Milwaukee

Aurora Cancer Care-Milwaukee

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Aurora Saint Luke's Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Aurora Sinai Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Froedtert and the Medical College of Wisconsin

Kathryn A. Bylow
Ph: 414-805-4380

Kathryn A. Bylow
Principal Investigator

Zablocki Veterans Administration Medical Center

Elizabeth M. Gore
Ph: 414-805-4380

Elizabeth M. Gore
Principal Investigator

Mukwonago

D N Greenwald Center

Timothy Robert Wassenaar
Ph: 262-928-7878

Timothy Robert Wassenaar
Principal Investigator

Oconomowoc

Oconomowoc Memorial Hospital-ProHealth Care Inc

Timothy Robert Wassenaar
Ph: 262-928-7878

Timothy Robert Wassenaar
Principal Investigator

Oconto Falls

Green Bay Oncology - Oconto Falls

Anthony John Jaslowski
Ph: 800-432-6049

Anthony John Jaslowski
Principal Investigator

Oshkosh

Vince Lombardi Cancer Clinic - Oshkosh

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Racine

Aurora Cancer Care-Racine

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Rice Lake

Marshfield Clinic-Rice Lake Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Sheboygan

Saint Nicholas Hospital

Anthony John Jaslowski
Ph: 800-432-6049

Anthony John Jaslowski
Principal Investigator

Vince Lombardi Cancer Clinic-Sheboygan

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Stevens Point

Marshfield Clinic Cancer Care at Saint Michael's Hospital

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Saint Michael's Hospital

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Sturgeon Bay

Green Bay Oncology - Sturgeon Bay

Anthony John Jaslowski
Ph: 800-432-6049

Anthony John Jaslowski
Principal Investigator

Summit

Aurora Medical Center in Summit

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Two Rivers

Vince Lombardi Cancer Clinic

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Waukesha

Aurora Cancer Care-Waukesha

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Waukesha Memorial Hospital

Timothy Robert Wassenaar
Ph: 262-928-7878

Timothy Robert Wassenaar
Principal Investigator

Wausau

Aspirus Regional Cancer Center

Christopher Gary Peterson
Ph: 877-405-6866

Christopher Gary Peterson
Principal Investigator

Wauwatosa

Aurora Cancer Care-Milwaukee West

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

West Allis

Aurora West Allis Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Weston

Diagnostic and Treatment Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Marshfield Clinic - Weston Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Wisconsin Rapids

Riverview Hospital

Ronnie James Kirschling
Ph: 877-405-6866

Ronnie James Kirschling
Principal Investigator

Canada

Alberta
Edmonton

Cross Cancer Institute

Scott Arthur North
Ph: 780-432-8500

Scott Arthur North
Principal Investigator

British Columbia
Vancouver

BCCA-Vancouver Cancer Centre

Kim Nguyen Chi
Ph: 888-939-3333

Kim Nguyen Chi
Principal Investigator

New Brunswick
Moncton

The Moncton Hospital

Mahmoud Abdelsalam
Ph: 506-857-5267

Mahmoud Abdelsalam
Principal Investigator

Saint John

Atlantic Health Sciences Corporation-Saint John Regional Hospital

Samantha Lee Gray
Ph: 506-648-6890

Samantha Lee Gray
Principal Investigator

Ontario
Cambridge

Cambridge Memorial Hospital

Edmond Emilien Chouinard
Ph: 888-823-5923
Email: ctsucontact@westat.com

Edmond Emilien Chouinard
Principal Investigator

Kitchener

Grand River Regional Cancer Centre at Grand River Hospital

Stacey Hubay
Ph: 519-749-4300ext2307

Stacey Hubay
Principal Investigator

Saskatchewan
Regina

Allan Blair Cancer Centre

Muhammad Salim
Ph: 306-766-2213

Muhammad Salim
Principal Investigator

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT01949337

Note: Information about participating sites on pharmaceutical industry trials may be incomplete. Please visit the ClinicalTrials.gov record via the link above for more information about participating sites.